A cholera outbreak in Sudan’s Darfur region killed 40 people and infected more than 2,300 in a single week, the worst in years.

The FDA has granted accelerated approval for Wegovy for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults.